NEW YORK, May 28, 2024 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and…
Month: May 2024
PARSIPPANY, N.J., May 28, 2024 /PRNewswire/ — Wyndham Hotels & Resorts, Inc. (NYSE: WH) (the “Company”) today announced that it successfully completed the repricing of its existing $1.1 billion Senior Secured Term Loan B Facility due May 2030 (the “Term Loan B”). The Term Loan B garnered…
PARSIPPANY, N.J., May 28, 2024 /PRNewswire/ — Wyndham Hotels & Resorts, Inc. (NYSE: WH) (the “Company”) today announced that it successfully completed the repricing of its existing $1.1 billion Senior Secured Term Loan B Facility due May 2030 (the “Term Loan B”). The Term Loan B garnered…
PARSIPPANY, N.J., May 28, 2024 /PRNewswire/ — Wyndham Hotels & Resorts, Inc. (NYSE: WH) (the “Company”) today announced that it successfully completed the repricing of its existing $1.1 billion Senior Secured Term Loan B Facility due May 2030 (the “Term Loan B”). The Term Loan B garnered…
—Phase 3 Study Achieves Primary Endpoint for Both Dosage Strengths of Brensocatib with Statistically Significant and Clinically Meaningful Reduction in Frequency of Pulmonary Exacerbations Versus Placebo— —Treatment with Brensocatib Also Achieves Statistical Significance on Multiple…
—Phase 3 Study Achieves Primary Endpoint for Both Dosage Strengths of Brensocatib with Statistically Significant and Clinically Meaningful Reduction in Frequency of Pulmonary Exacerbations Versus Placebo— —Treatment with Brensocatib Also Achieves Statistical Significance on Multiple…
—Phase 3 Study Achieves Primary Endpoint for Both Dosage Strengths of Brensocatib with Statistically Significant and Clinically Meaningful Reduction in Frequency of Pulmonary Exacerbations Versus Placebo— —Treatment with Brensocatib Also Achieves Statistical Significance on Multiple…
Record revenue and continued strong profitability; reiterates guidance and declares an $8 million dividend for the first quarter of 2024 AZOUR, Israel, May 28, 2024 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN) today announced its consolidated financial results for the…
Record revenue and continued strong profitability; reiterates guidance and declares an $8 million dividend for the first quarter of 2024 AZOUR, Israel, May 28, 2024 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN) today announced its consolidated financial results for the…
Record revenue and continued strong profitability; reiterates guidance and declares an $8 million dividend for the first quarter of 2024 AZOUR, Israel, May 28, 2024 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN) today announced its consolidated financial results for the…
